# Quest Diagnostics Inc (DGX) FY2026 Q2 Balance Sheet

- Company: Quest Diagnostics Inc (DGX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-23, accession number 0001022079-26-000070
- Page: https://plicit.ai/financials/dgx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/dgx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 16,939,000,000 US dollars
- **Current assets**: 2,844,000,000 US dollars
- **Non-current assets**: 14,095,000,000 US dollars
- **Liabilities (calculated)**: 9,040,000,000 US dollars
- **Current liabilities**: 1,788,000,000 US dollars
- **Non-current liabilities**: 7,252,000,000 US dollars
- **Equity**: 7,819,000,000 US dollars
- **Redeemable noncontrolling interest**: 80,000,000 US dollars
- **Noncontrolling interest**: 303,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net of allowance for credit losses of $28 and $25 as of June 30, 2026 and December 31, 2025, respectively**: 1,666,000,000 US dollars
- **Cash and cash equivalents**: 626,000,000 US dollars
- **Prepaid expenses and other current assets**: 319,000,000 US dollars
- **Inventories**: 233,000,000 US dollars
- **Goodwill**: 9,112,000,000 US dollars
- **Property, plant and equipment, net**: 2,219,000,000 US dollars
- **Intangible assets, net**: 1,672,000,000 US dollars
- **Operating lease right-of-use assets**: 678,000,000 US dollars
- **Other assets**: 277,000,000 US dollars
- **Investments in equity method investees**: 137,000,000 US dollars
- **Accounts payable and accrued expenses**: 1,598,000,000 US dollars
- **Current portion of long-term operating lease liabilities**: 180,000,000 US dollars
- **Less: Current portion of long-term debt**: 10,000,000 US dollars
- **Long-term debt**: 5,632,000,000 US dollars
- **Other liabilities**: 1,059,000,000 US dollars
- **Long-term operating lease liabilities**: 561,000,000 US dollars
- **Retained earnings**: 10,374,000,000 US dollars
- **Additional paid-in capital**: 2,374,000,000 US dollars
- **Common stock, par value $0.01 per share; 600 shares authorized as of both June 30, 2026 and December 31, 2025; 162 shares issued as of both June 30, 2026 and December 31, 2025**: 2,000,000 US dollars
- **Noncontrolling interests**: 303,000,000 US dollars
- **Treasury stock, at cost; 52 shares as of both June 30, 2026 and December 31, 2025**: negative 5,172,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 62,000,000 US dollars
- **Gross equity (calculated)**: 13,053,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus temporary equity plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.